Literature DB >> 17031633

Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.

Markus Uhl1, Ulrich Saueressig, Gabriele Koehler, Udo Kontny, Charlotte Niemeyer, Wilfried Reichardt, Kamil Ilyasof, Thorsten Bley, Mathias Langer.   

Abstract

BACKGROUND: During successful chemotherapy of osteosarcomas tumour size does not diminish significantly because the therapy has limited impact on the mineralized matrix of the tumour. Treatment response is considered successful if, histologically, more than 90% of tumour cells show necrosis.
OBJECTIVE: To determine if osteosarcomas change their water diffusion during preoperative chemotherapy in relation to the amount of tumour necrosis.
MATERIALS AND METHODS: Eight patients (age 11-19 years) with histologically proven limb osteosarcoma underwent T1-weighted, fat-suppressed T2-weighted and contrast-enhanced T1-weighted spin-echo imaging together with diffusion-weighted EPI sequences (b = 700) at 1.5 T before and after five cycles of standard chemotherapy. Tumour volume and apparent diffusion coefficient (ADC) maps were calculated before and after chemotherapy. The degree of tumour necrosis after chemotherapy was assessed using the histological Salzer-Kuntschik classification (grades 1-6).
RESULTS: During chemotherapy, the ADC values of osteosarcomas changed significantly. The ADC of untreated tumour was 2.1 +/- 0.4 x 10(-3) mm(2)/s (mean +/- SD) (95% CI 1.6-2.0). The ADC of chemotherapy-treated sarcomas was 2.5 +/- 0.4 x 10(-3) mm(2)/s (95% CI 1.8-2.2). Necrotic areas, which were confirmed by macroscopic examination, showed ADC values up to 2.7 x 10(-3) mm(2)/s. Four patients with little viable tumour tissue within the neoplasm (Salzer-Kuntschik grades 1-2) had an increase in ADC of 0.4 up to 0.7 x 10(-3) mm(2)/s. Four patients with larger areas of viable tumour (Salzer-Kuntschik grade 4) showed a lesser increase in ADC of 0.0 up to 0.3 x 10(-3) mm(2)/s. The differences in ADC values in tumour tissue before and after chemotherapy were highly significant (P = 0.01).
CONCLUSION: During chemotherapy of osteosarcomas, tumour ADC changes are related to the degree of tumour necrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031633     DOI: 10.1007/s00247-006-0324-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  13 in total

1.  Accuracy of MR imaging for detecting epiphyseal extension of osteosarcoma.

Authors:  F A Hoffer; A Y Nikanorov; W E Reddick; S M Bodner; X Xiong; D Jones-Wallace; S A Gronemeyer; B N Rao; W M Kauffman; T Laor
Journal:  Pediatr Radiol       Date:  2000-05

Review 2.  Advances in MR imaging of pediatric musculoskeletal neoplasms.

Authors:  P Lang; J O Johnston; F Arenal-Romero; C A Gooding
Journal:  Magn Reson Imaging Clin N Am       Date:  1998-08       Impact factor: 2.266

3.  Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.

Authors:  Rebecca J Theilmann; Rebecca Borders; Theodore P Trouard; Guowei Xia; Eric Outwater; James Ranger-Moore; Robert J Gillies; Alison Stopeck
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.

Authors:  Markus Uhl; Ulrich Saueressig; Miriam van Buiren; Udo Kontny; Charlotte Niemeyer; Gabriele Köhler; Kamil Ilyasov; Mathias Langer
Journal:  Invest Radiol       Date:  2006-08       Impact factor: 6.016

5.  Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.

Authors:  Harriet C Thoeny; Frederik De Keyzer; Feng Chen; Yicheng Ni; Willy Landuyt; Eric K Verbeken; Hilde Bosmans; Guy Marchal; Robert Hermans
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

6.  Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.

Authors:  Harriet C Thoeny; Frederik De Keyzer; Vincent Vandecaveye; Feng Chen; Xihe Sun; Hilde Bosmans; Robert Hermans; Eric K Verbeken; Chris Boesch; Guy Marchal; Willy Landuyt; Yicheng Ni
Journal:  Radiology       Date:  2005-09-28       Impact factor: 11.105

7.  Musculoskeletal neoplasms after intraarterial chemotherapy: correlation of MR images with pathologic specimens.

Authors:  R B Sanchez; S F Quinn; A Walling; J Estrada; H Greenberg
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

Review 8.  Diffusion-weighted imaging of the musculoskeletal system in humans.

Authors:  A Baur; M F Reiser
Journal:  Skeletal Radiol       Date:  2000-10       Impact factor: 2.199

9.  Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging.

Authors:  P Lang; M F Wendland; M Saeed; A Gindele; W Rosenau; A Mathur; C A Gooding; H K Genant
Journal:  Radiology       Date:  1998-01       Impact factor: 11.105

10.  Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization.

Authors:  Jie Deng; Frank H Miller; Thomas K Rhee; Kent T Sato; Mary F Mulcahy; Laura M Kulik; Riad Salem; Reed A Omary; Andrew C Larson
Journal:  J Vasc Interv Radiol       Date:  2006-07       Impact factor: 3.464

View more
  36 in total

Review 1.  Whole-body MR imaging, bone diffusion imaging: how and why?

Authors:  Diego Jaramillo
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 2.  Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts.

Authors:  Hee Kang; Ho Yun Lee; Kyung Soo Lee; Jae-Hun Kim
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

3.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

4.  Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.

Authors:  C Baunin; G Schmidt; K Baumstarck; C Bouvier; J C Gentet; A Aschero; A Ruocco; B Bourlière; G Gorincour; C Desvignes; N Colavolpe; G Bollini; P Auqier; P Petit
Journal:  Skeletal Radiol       Date:  2012-02-09       Impact factor: 2.199

5.  Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis.

Authors:  Jyoti Bajpai; Shivanand Gamnagatti; Rakesh Kumar; Vishnubhatla Sreenivas; Mehar Chand Sharma; Shah Alam Khan; Shishir Rastogi; Arun Malhotra; Rajni Safaya; Sameer Bakhshi
Journal:  Pediatr Radiol       Date:  2010-10-27

Review 6.  Diffusion-weighted and diffusion tensor imaging for pediatric musculoskeletal disorders.

Authors:  John D MacKenzie; Leonardo Gonzalez; Andrea Hernandez; Kai Ruppert; Diego Jaramillo
Journal:  Pediatr Radiol       Date:  2007-06-28

7.  [Pediatric bone marrow alterations].

Authors:  Sebastian Berg
Journal:  Radiologe       Date:  2021-01-05       Impact factor: 0.635

8.  Value of diffusion-weighted imaging for evaluating chemotherapy response in osteosarcoma: A meta-analysis.

Authors:  Tadahiko Kubo; Taisuke Furuta; Muhammad P Johan; Mitsuo Ochi; Nobuo Adachi
Journal:  Mol Clin Oncol       Date:  2017-05-29

Review 9.  Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques.

Authors:  Laura M Fayad; Michael A Jacobs; Xin Wang; John A Carrino; David A Bluemke
Journal:  Radiology       Date:  2012-11       Impact factor: 11.105

10.  Diffusion-weighted MRI for detection and differentiation of musculoskeletal tumorous and tumor-like lesions in pediatric patients.

Authors:  Henning Neubauer; Laura Evangelista; Nicole Hassold; Beate Winkler; Paul Gerhardt Schlegel; Herbert Köstler; Dietbert Hahn; Meinrad Beer
Journal:  World J Pediatr       Date:  2012-11-15       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.